The article below may contain offensive and/or incorrect content.
Glutamate-modulating agents are of increasing interest in obsessive-compulsive disorder (OCD). Current pharmacotherapies for OCD target the serotonin and dopamine systems, and are limited in efficacy. N-acetylcysteine (NAC) is an over-the-counter amino acid supplement that inhibits glutamate neurotransmission and has been shown in preliminary studies to reduce symptoms in OCD and related compulsive disorders. Despite growing interest in NAC as a novel psychiatric medication, no studies currently exist examining the effects of NAC in animal models of compulsive disorders. Here, we investigate NAC in a well-validated mouse model of OCD that is predictive of treatment efficacy as well as the time course for therapeutic onset of OCD medications. NAC (60 mg/kg/day or 120 mg/kg/day) was administered via the drinking water of mice for 3 weeks prior to behavioral testing. Mice were tested in the delayed alternation task (DAT) and open field test following acute serotonin 1B receptor (5-HT1B) agonist challenge to induce OCD-related behavior. We found that both doses of NAC blocked 5-HT1B agonist-induced deficits on the DAT. In a separate study, we administered NAC (60 mg/kg/day) for 1 week or 3 weeks in the drinking water of mice prior to examining OCD-related behavior. We found that blockade of 5-HT1B agonist-induced OCD-like behavior is present at 3 weeks, but not 1 week, of NAC treatment. Together, our findings suggest that NAC is a novel OCD treatment with potential utility as monotherapy and therapeutic effects that emerge on a time-course similar to established medications. (PsycINFO Database Record (c) 2018 APA, all rights reserved)





Departments
Authors
Libraries
Current Articles
- Article Correctness Is Author's Responsibility: Video » NIMH Expert Dr. Krystal Lewis Discusses Managing Stress & Anxiety
- Article Correctness Is Author's Responsibility: Scientific Meeting » NIMH Livestream Event: Managing Stress and Anxiety
- Article Correctness Is Author's Responsibility: A third of Americans don't see systemic racism as a barrier to good health
- Article Correctness Is Author's Responsibility: What brain imaging tells us about decluttering our minds
- Article Correctness Is Author's Responsibility: Blog Post » Showing Support for Basic Researchers
- Article Correctness Is Author's Responsibility: How to reduce news-related stress for better mental health
- Article Correctness Is Author's Responsibility: Five myths about loneliness
- Article Correctness Is Author's Responsibility: How to help someone struggling with suicidal ideation
- Article Correctness Is Author's Responsibility: Better sleep hygiene is crucial when you're anxious
- Article Correctness Is Author's Responsibility: How to remotivate kids for more distance learning
- Article Correctness Is Author's Responsibility: How to set goals you’ll actually achieve
- Article Correctness Is Author's Responsibility: To 'keep sharp' this year, keep learning
- Article Correctness Is Author's Responsibility: Mental health is one of the biggest issues facing 2021
- Article Correctness Is Author's Responsibility: Reasons to prioritize better sleep in 2021
- Article Correctness Is Author's Responsibility: Coping with post-holiday blues amid coronavirus
- Article Correctness Is Author's Responsibility: Video » The NIMH Director’s Innovation Speaker Series: Pursuing an Innovation Agenda: A New Healthcare Architecture
- Article Correctness Is Author's Responsibility: Pandemic worsening domestic abuse
- Article Correctness Is Author's Responsibility: Young people's anxiety levels nearly doubled during first Covid-19 lockdown
- Article Correctness Is Author's Responsibility: Video » NIMH Director’s Innovation Speaker Series: Decision-Making and Computational Psychiatry
- Article Correctness Is Author's Responsibility: Blog Post » The Lives Lost to COVID-19